Koroner bypass cerrahisinde aantegrad kardiyopleji yönteminin antegrad-retrograd kardiyopleji yöntemi ile inflamatuar cevap ve sol ventrikül sistolik fonksiyonları açısından kıyaslanması: prospektif randomize çalışma

Year 2018, , 179 - 184, 30.09.2018

Mustafa Cüneyt Çiçek , Niyazi Görmüş Kadir Durgut Mehmet Kayrak Aysun Toker İşık Solak Görmüş Ömer Faruk Çiçek

https://doi.org/10.18663/tjcl.432111

Cited By: 1

Abstract

Amaç: Özellikle proksimal darlığı olan koroner arter
hastalarında veya ciddi miyokardiyal hipertrofisi olan hastalarda antegrad
kardiyoplejinin homojen olmayan dağılımı ciddi bir problemdir. Bu prospektif
randomize çalışmada, kombine antegrad-retrograd kardiyoplejinin sadece antegrad
tekniğe kıyasla erken dönemde daha iyi miyokardiyal koruma sağlaması ve daha iyi
laboratuar sonuçları ile ilişkisi değerlendirilmiştir.

Gereç ve Yöntemler: Koroner bypass cerrahisi uygulanan 60 hasta (45 (%75)
erkek, 15 (%25) kadın) çalışmaya dahil edilmiştir ve iki grupta incelenmiştir:
Grup 1’de 30 hastaya aort kökünden antegrad ve koroner sinusten retrograd yolla
kombine kardiyopleji; Grup 2’de ise 30 hastaya aort kökünden antegrad
kardiyopleji verildi. Preoperatif, intraoperatif ve postoperative altıncı günde
alınan kan örneklerinden CK-MB, TpI, TNF- α, IL-1, IMA, ICAM-1 ve BNP parametreleri
çalışıldı. Hastalar preoperative olarak ve postoperative altıncı günde
transtorasik ekokardiyografi ile değerlendirildi.

Bulgular: Postoperatif ortalama EF düşüşü Grup 1’de Grup 2’ye
kıyasla istatistiksel olarak anlamlı şekilde daha az oldu (4.13 ± 9.09 ve 8.90
± 10.76, sırayla Grup 1 ve Grup 2, p=0.046). TNF- α seviyelerindeki değişimin
büyüklüğü kıyaslandığında Grup 2’deki artışın daha fazla olduğu bulunmuştur
(p=0.047).

Sonuçlar: Antegrad ve retrograd kardiyoplejinin birlikte
uygulanmasının, erken postoperatif dönemde tek başına antegrad kardiyoplejiye
göre daha iyi miyokardiyal koruma sağlayabileceği sonucuna vardık.

Keywords

antegrad, inflamasyon, kardiyopleji, miyokardiyal koruma, retrograd

Comparison of effect of antegrade with combined antegrade/retrograde cardioplegia on inflammatory response and left ventricular systolic function in coronary bypass surgery: a prospective randomized study

Abstract

Aim: Nonhomogeneous distribution of antegrade cardioplegia
especially in cases with severe myocardial hypertrophy or proximal stenosis of
coronary arteries may be a serious problem. This prospective randomized study
was designed to determine whether combined antegrade–retrograde cardioplegia
provides improved myocardial protection in the early period and is associated
with better laboratory results compared with antegrade technique alone.

Material and Methods: A total of 60 patients who underwent coronary artery
bypass grafting surgery, 45 (75%) males and 15 (25%) females, were included in
the study as 2 groups: In Group 1, 30 patients were given the combined
cardioplegia solution antegrade via the aortic root and retrograde via the
coronary sinus, in Group 2, 30 patients were given only antegrade cardioplegia
solution via the aortic root. The CK-MB, TpI, TNF- α, IL-1, IMA, ICAM-1, and
BNP parameters were studied in the blood samples which were taken
preoperatively, intraoperatively and postoperative sixth day. The patients were
evaluated preoperatively and on the sixth postoperative day using transthoracic
echocardiography.

Results: The postoperative mean EF decrease was significantly
lower in Group 1 compared to Group 2 (4.13 ± 9.09 vs 8.90 ± 10.76 in Group 1
vs. Group 2, respectively, p=0.046). When the change in TNF-α levels were
compared between groups 1 and 2, the magnitude of increase in TNF-α was
significantly higher in Group 2 (p=0.047).

Conclusion: We concluded that co-administration of antegrade and
retrograde cardioplegia may provide improved myocardial protection compared to
antegrade cardioplegia method alone in the early postoperative period.

Keywords

antegrade, cardioplegia, inflammation, myocardial protection, retrograde

References

• 1. Bolling SE, Flaherty JT, Bulkley BH, Gott VL, Gardner TJ. Improved myocardial preservation during global ischemia by continuous retrograde coronary sinus perfusion. J Thorac Cardiovasc Surg 1983; 86: 659-66.
• 2. Casthely PA, Shah C, Mekhjian H et al. Left ventricular diastolic function after coronary artery bypass grafting: a correlative study with three different myocardial protection techniques. J Thorac Cardiovasc Surg 1997; 114: 254-60.
• 3. Fabian JR, Deloche A, Swanson J, Carpentier A. Retrograde cardioplegia through the right atrium. Ann Thorac Surg 1986; 41: 101-2.
• 4. Bhyana J, Kalmbach T, Booth FV, Mentzer M, Schimert G. Combined antegrade/retrograde cardioplegia for myocardial protection: a clinical study. J Thorac Cardiovasc Surg 1989; 98: 956-60.
• 5. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 2000; 19: 311-15.
• 6. Fiore AC, Naunheime KS, Kaiser GC et al. Coronary sinus versus aortic root perfusion with blood cardioplegia in elective myocardial revascularization. Ann Thorac Surg 1989; 47: 684-88.
• 7. Kulshrestha P, Rousou JA, Emgelman RM et al. Does warm blood retrograde cardioplegia preserve right ventricular function? Ann Thorac Surg 2001; 72: 1572-75.
• 8. Flack JE 3rd, Cook JR, May SJ et al. Does cardioplegia type affect outcome and survival in patients with advanced left ventricular dysfunction? Results from the CABG Patch Trial. Circulation 2000; 102: 84–89.
• 9. Rao V, Cohen G, Weisel RD et al. Optimal flow rates for integrated cardioplegia. J Thorac Cardiovasc Surg 1998; 115: 226-35.
• 10. Arom KV, Emery RW, Petersen RJ, Bero JW. Evaluation of 7,000+ patients with two different routes of cardioplegia. Ann Thorac Surg 1997; 63: 1619-24.
• 11. Aldea GS, Hou D, Fonger JD, Shemin RJ. Inhomogeneous and complementary antegrade and retrograde delivery of cardioplegic solution in the absence of coronary artery obstruction. J Thorac Cardiovasc Surg 1994; 107: 499-504.
• 12. Jacquet L, Noirhomme P, El Khoury G et al. Cardiac troponin I as an early marker of myocardial damage after coronary bypass surgery. Eur J Cardiothorac Surg 1998; 13: 378-84.
• 13. Kutsal A, Saydam GS, Yucel D, Balk M. Changes in serum levels of CKMB, LDH, LDH1, SGOT and myoglobin due to cardiac surgery. J Cardiovasc Surg 1991; 32: 516-21.
• 14. Chello M, Mastroroberto P, Perticone F et al. Plasma levels of atrial and brain natriuretic peptides as indicators of recovery of left ventricular systolic function after coronary artery bypass. Eur J Cardiathorac Surg 2001; 20: 140-46.
• 15. Wei CM, Heublein DM, Perrella MA et al. Natriuretic peptide system in human heart failure. Circulation 1993; 88: 1004-9.
• 16. Saribulbul O, Alat I, Coskun S et al. The role of brain natriuretic peptide in the prediction of cardiac performance in coronary artery bypass grafting. Tex Heart Inst J 2003; 30: 298-304.
• 17. Song MH, Kobayashi Y, Michi H. Clinical implication of atrial and brain natriuretic peptide in coronary artery bypass grafting. Asian Cardiovasc Thorac Ann 2004; 12: 41-46.
• 18. Matsumoto A, Hirata Y, Momomura S et al. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. Am Heart J 1995; 129: 139-45.
• 19. Yasue H, Yoshimura M, Sumida H et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195-203.